Citadel Advisors’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-255,772
| Closed | -$3.88M | – | 10557 |
|
|
2019
Q4 | $3.88M | Sell |
255,772
-461,210
| -64% | -$3.98M | ﹤0.01% | 3425 |
|
|
2019
Q3 | $4.58M | Buy |
716,982
+497,647
| +227% | +$4.16M | ﹤0.01% | 3235 |
|
|
2019
Q2 | $2.1M | Sell |
219,335
-290,316
| -57% | -$3.13M | ﹤0.01% | 4433 |
|
|
2019
Q1 | $6.91M | Buy |
+509,651
| New | +$4.25M | ﹤0.01% | 2535 |
|
|
2018
Q3 | – | Sell |
-461,497
| Closed | -$4.65M | – | 9959 |
|
|
2018
Q2 | $4.25M | Sell |
461,497
-175,215
| -28% | -$1.63M | ﹤0.01% | 2982 |
|
|
2018
Q1 | $5.09M | Buy |
636,712
+288,221
| +83% | +$6.27M | ﹤0.01% | 2432 |
|
|
2017
Q4 | $9.69M | Sell |
348,491
-145,307
| -29% | -$3.85M | 0.01% | 1765 |
|
|
2017
Q3 | $13.3M | Buy |
493,798
+486,048
| +6,272% | +$12.7M | 0.01% | 1364 |
|
|
2017
Q2 | $226K | Sell |
7,750
-52,999
| -87% | -$1.61M | ﹤0.01% | 6375 |
|
|
2017
Q1 | $2.07M | Buy |
+60,749
| New | +$1.96M | ﹤0.01% | 3027 |
|
|
2016
Q2 | – | Sell |
-113,089
| Closed | -$3.12M | – | 7684 |
|
|
2016
Q1 | $2.34M | Sell |
113,089
-40,534
| -26% | -$995K | ﹤0.01% | 2480 |
|
|
2015
Q4 | $5.32M | Sell |
153,623
-82,059
| -35% | -$2.36M | 0.01% | 1767 |
|
|
2015
Q3 | $5.5M | Buy |
+235,682
| New | +$5.73M | 0.01% | 1845 |
|
Citadel Advisors's DERM Position: Q1 2020 in Review
Citadel Advisors sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 255,772 shares — an estimated $3.88M sold.
Citadel Advisors first reported a position in DERM in Q3 2015 and held it in 13 quarters. The position peaked at $13.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Citadel Advisors reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 255,772 Dermira, Inc. shares in Q1 2020, an estimated $3.88M.
- Citadel Advisors first reported a position in Dermira, Inc. in Q3 2015 and held it in 13 quarters.
- Citadel Advisors's Dermira, Inc. position peaked at $13.3M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.